ReviewResearch and reports in urology2025
Epidemiology and Management of Kidney Stone Disease - Current Insights.
Review in Research and reports in urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Sex-specific associations of traditional and novel anthropometric indices with incident kidney stone disease: a 10-year longitudinal cohort study.Urolithiasis · 2026Article
- Identification of key molecules and pathways in CaOx crystal-induced renal injury based on metabolomics and proteomics.International urology and nephrology · 2026Article
- Single-use vs. reusable flexible ureteroscopes: what do our patients prefer?World journal of urology · 2026Article
- Article
- Two decades of kidney stone interventional trials on clinicaltrials.gov: a registry-based landscape analysis of design, endpoints, and dissemination.Urolithiasis · 2026Article
- Protective effects of Rhus coriaria L. fruit extract against experimental calcium oxalate nephrolithiasis via modulation of oxidative stress and renal injury.Urolithiasis · 2026Article
- Computed Tomography-Derived visceral fat area is associated with increased risk of kidney stone recurrence.Urolithiasis · 2026Article
- The roles of free-fatty acid receptors in the pathophysiology of renal disorders.The Journal of pharmacology and experimental therapeutics · 2026Review
- Effect of Adjuvant Silodosin on Stone Clearance After Extracorporeal Shock Wave Lithotripsy for Renal Stones: A Randomised Controlled Trial.Journal of clinical medicine · 2026Article
- Identification of Potential Oxidative Stress-Related Causal Genes for Calculus of Kidney and Ureter: A Multi-Omics Mendelian Randomization Analysis.Kidney diseases (Basel, Switzerland)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nephrolithiasis is a common global urological disorder, with incidence rates being as high as 13% in some regions of North America, contributing to substantial healthcare burdens. In 2021, 106 million new cases were reported worldwide, predominantly in men, reflecting a 27% rise since 2000. Regional disparities are notable, with Eastern Europe showing the highest rates (3,560 per 100,000). Management has evolved from open surgery to minimally invasive, precision endourological techniques, driven by innovations such as advanced lasers, digital ureteroscopes, artificial intelligence, virtual reality training, and robotic-assisted procedures, these advances have enhanced stone-free rates and reduced complications This review provides a comprehensive analysis of the epidemiology and contemporary management of kidney stone disease especially analysing variables affecting the disease including gender, age, geography and climate, occupational exposure, dietary lifestyle, and systemic diseases. Understanding the multifactorial epidemiology of nephrolithiasis is essential for effective prevention, while modern technological interventions are reshaping treatment standards and improving patient outcomes by offering individualized treatment options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.